LONDON BROKER RATINGS: Citigroup lifts Rightmove and Relx
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
| Price | 88.94p on 08-04-2026 at 12:48:55 |
|---|---|
| Change | 6.00p 7.23% |
| Buy | 89.02p |
| Sell | 88.94p |
| Last Trade: | Sell 551.00 at 88.892p |
| Day's Volume: | 24,815,371 |
| Last Close: | 82.94p |
| Open: | 90.00p |
| ISIN: | GB0008782301 |
| Day's Range | 87.24p - 90.00p |
| 52wk Range: | 82.58p - 123.85p |
| Market Capitalisation: | £3.12b |
| VWAP: | 88.58202p |
| Shares in Issue: | 3.51b |
Taylor Wimpey (TW.) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 551 | 88.892p | Negotiated Trade |
13:48:48 - 08-Apr-26 |
| Buy* | 5,000 | 88.96p | Ordinary |
13:48:46 - 08-Apr-26 |
| Sell* | 1,000 | 88.892p | Negotiated Trade |
13:48:39 - 08-Apr-26 |
| Buy* | 907 | 88.94p | Automatic Execution |
13:48:34 - 08-Apr-26 |
| Buy* | 190,115 | 88.969p | Suspected BUY Trade |
13:48:19 - 08-Apr-26 |
| Buy* | 2,818 | 88.949p | Ordinary |
13:47:54 - 08-Apr-26 |
| Sell* | 2,332 | 88.94p | Automatic Execution |
13:47:40 - 08-Apr-26 |
| Buy* | 800 | 89.00p | SI Trade |
13:47:30 - 08-Apr-26 |
| Sell* | 2,392 | 88.94p | Automatic Execution |
13:47:30 - 08-Apr-26 |
| Buy* | 694 | 88.94p | Automatic Execution |
13:47:15 - 08-Apr-26 |
Taylor Wimpey (TW.) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 1st Apr 2026 1:36 pm | RNS | Total Voting Rights |
| 30th Mar 2026 2:19 pm | RNS | Holding(s) in Company |
| 26th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 25th Mar 2026 3:00 pm | RNS | Director/PDMR Shareholding |
| 23rd Mar 2026 2:22 pm | RNS | Holding(s) in Company |
| 20th Mar 2026 3:37 pm | RNS | Annual Financial Report and Notice of Meeting |
| 19th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 12th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 10th Mar 2026 3:23 pm | RNS | Director/PDMR Shareholding |